Dunad Therapeutics logo

Dunad Therapeutics

Tunable covalent chemistry with a deep understanding of disease biology to develop transformational medicines.

13 employees · est. 2020 · Cambridge, United States

VS
Matchpoint Therapeutics logo

Matchpoint Therapeutics

Acing the future of covalent medicines

32 employees · est. 2021

Dunad Therapeutics is the older company (2020 vs 2021).

Side-by-Side Comparison

Dunad Therapeutics Matchpoint Therapeutics
Founded
2020 older 2021
Headquarters
Cambridge, United States Not tracked yet
Employees
13 32
Industry
Biotechnology, Pharmaceutical Biotechnology, Pharmaceutical
Funding Stage
Series A Series A
Total Funding
$29.00M $100.00M
Funding Rounds
2 2
Services
Development of transformational medicines, Drug discovery for neurodegenerative diseases, Research and development in covalent chemistry Discovery of precision small molecule medicines, Chemoproteomics screening, Development of covalent drug libraries, Machine learning-driven drug design
Target Customers
Patients with neurodegenerative diseases, Healthcare providers, Pharmaceutical partners Pharmaceutical companies, Biotech investors, Healthcare providers, Research institutions in immunology
Taxonomy
Tunable Covalent Chemistry, Disease Biology, Transformational Medicines, Targeted Protein Degradation, Biopharmaceuticals, CNS Disease, Oncology, Drug Discovery, Drug Development, Selective Targeting, Durable Therapies Covalent Medicines, Immunology, Precision Medicine, Chemoproteomics, Machine Learning In Biotech, Covalency, Drug Discovery, Pharmaceutical Research, Immune Diseases, Chemical Library Evolution, ACE Platform, Biotech Innovation
Website
dunadtx.com matchpointtx.com
Dunad Therapeutics logo

About Dunad Therapeutics

Dunad Therapeutics is a pioneering company in the Biotechnology and Pharmaceutical industries, founded in 2020 and headquartered in the United States. The company is driven by its slogan: "Tunable covalent chemistry with a deep understanding of disease biology to develop transformational medicines."...

Matchpoint Therapeutics logo

About Matchpoint Therapeutics

Matchpoint Therapeutics, founded in 2021, is at the forefront of innovation in the Biotechnology and Pharmaceutical industries. With the slogan "Acing the future of covalent medicines," the company is committed to revolutionizing the treatment landscape for immune diseases and other serious conditio...

We will tell you when either one moves

BounceWatch watches Dunad Therapeutics and Matchpoint Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Dunad Therapeutics and Matchpoint Therapeutic... — by email.

Frequently Asked Questions

Dunad Therapeutics — Tunable covalent chemistry with a deep understanding of disease biology to develop transformational medicines.. Matchpoint Therapeutics — Acing the future of covalent medicines. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Dunad Therapeutics has raised $29.00M while Matchpoint Therapeutics has raised $100.00M.
Dunad Therapeutics and Matchpoint Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Dunad Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Dunad Therapeutics on 15 Jun 2026, and Matchpoint Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes